Treatment
Rabeprazole clinical trials
We’re tracking 6 recruiting studies that include Rabeprazole, each written for real people, not researchers, below.
Recruiting studies
- NCT07010107RecruitingPhase 3
Testing anaprazole for moderate to severe reflux esophagitis
This trial tests a new medicine called anaprazole for people with moderate to severe reflux esophagitis (chronic heartburn and damage to the food pipe). It compares anaprazole to a standard treatment to see which works better and is safer.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07797478RecruitingPhase 1
Study of ro7890597 in healthy volunteers
This study tests a new medicine called ro7890597 in healthy adults to see how safe it is and how the body handles it. Participation could help determine if this medicine is suitable for future patients.
Lenexa, KansasAges 18–65 - NCT07471867RecruitingPhase 4
Testing a new stomach medicine for heart patients on clopidogrel
This trial tests if a new stomach acid medicine (Zastaprazan) affects how well clopidogrel works in heart patients who have had a stent placed. It aims to help people who need both clopidogrel and a stomach acid drug after a procedure.
Yongin-si, Gyeonggi-doAges 19 years+ - NCT07358130Recruiting
Comparing two treatments for H. pylori infection
This trial tests two different ways to treat Helicobacter pylori (H. pylori), a bacteria that can cause stomach ulcers. One treatment combines three medicines (bismuth, amoxicillin, and vonoprazan), and the other uses four medicines (bismuth quadruple therapy). The goal is to see which works better.
Kaohsiung CityAges 18 years+ - NCT07122024RecruitingPhase 4
Testing a dual therapy for H. pylori treatment
This trial tests a two-drug treatment (keverprazan and amoxicillin) for people who have H. pylori and have not been treated for it before. The goal is to see if this newer combination works well and is safe.
Hangzhou, ZhejiangAges 18–65 - NCT06349486Recruiting
Comparing new treatments for H. pylori infection
This trial compares three different medication combinations to see which works best for treating H. pylori infection. If you have H. pylori and haven't been treated yet, you may be able to join.
Kaohsiung CityAges 18 years+
What Rabeprazole is being studied for
Conditions with recruiting Rabeprazole studies.
Common questions
- Are there clinical trials studying Rabeprazole?
- Yes. Clin2 currently lists 6 recruiting studies that include Rabeprazole, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Rabeprazole trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Rabeprazole an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Rabeprazole or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.